Related Experiment Video
Updated: Jan 22, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail
Zhong-Yi Qin1, Tao Wang1, Siyuan Su2
1Department of Gastroenterology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, P. R. China.
Abstract:
Cancer metastasis, a leading cause of death in patients, is associated with aberrant expression of epigenetic modifiers, yet it remains poorly defined how epigenetic readers drive metastatic growth and whether epigenetic readers are targetable to control metastasis. Here, we report that bromodomain-containing protein 4 (BRD4), a histone acetylation reader and emerging anticancer therapeutic target, promotes progression and metastasis of gastric cancer. The abundance of BRD4 in human gastric cancer tissues correlated with shortened metastasis-free gastric cancer patient survival. Consistently, BRD4 maintained invasiveness of cancer cells in vitro and their dissemination at distal organs in vivo. Surprisingly, BRD4 function in this context was independent of its putative transcriptional targets such as MYC or BCL2, but rather through stabilization of Snail at posttranslational levels. In an acetylation-dependent manner, BRD4 recognized acetylated lysine 146 (K146) and K187 on Snail to prevent Snail recognition by its E3 ubiquitin ligases FBXL14 and β-Trcp1, thereby inhibiting Snail polyubiquitination and proteasomal degradation. Accordingly, genome-wide transcriptome analyses identified that BRD4 and Snail regulate a partially shared metastatic gene signature in gastric cancer cells. These findings reveal a noncanonical posttranscriptional regulatory function of BRD4 in maintaining cancer growth and dissemination, with immediate translational implications for treating gastric metastatic malignancies with clinically available bromodomain inhibitors. SIGNIFICANCE: These findings reveal a novel posttranscriptional regulatory function of the epigenetic reader BRD4 in cancer metastasis via stabilizing Snail, with immediate translational implication for treating metastatic malignancies with clinically available bromodomain inhibitors. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/79/19/4869/F1.large.jpg.
Insights
Bromodomain-containing protein 4 (BRD4) drives gastric cancer metastasis by stabilizing Snail. Targeting BRD4 offers a new therapeutic strategy for metastatic gastric cancer patients.
Area of Science:
- Oncology
- Epigenetics
- Cancer Metastasis
Background:
- Cancer metastasis is a major cause of cancer-related mortality.
- Epigenetic modifiers play a role in metastasis, but their specific functions are not fully understood.
- Bromodomain-containing protein 4 (BRD4) is an epigenetic reader and a potential anticancer target.
Purpose of the Study:
- To investigate the role of BRD4 in gastric cancer progression and metastasis.
- To determine the mechanism by which BRD4 promotes metastasis.
- To explore the therapeutic potential of targeting BRD4 in metastatic gastric cancer.
Main Methods:
- Analysis of BRD4 abundance in human gastric cancer tissues.
- In vitro and in vivo studies to assess the role of BRD4 in cancer cell invasiveness and dissemination.
- Investigation of BRD4's interaction with Snail at the posttranslational level.
- Genome-wide transcriptome analyses to identify shared target genes of BRD4 and Snail.
Main Results:
- BRD4 abundance correlates with reduced metastasis-free survival in gastric cancer patients.
- BRD4 enhances cancer cell invasiveness and dissemination.
- BRD4 stabilizes Snail by preventing its ubiquitylation and degradation, independent of canonical transcriptional targets.
- BRD4 and Snail regulate a common set of genes involved in metastasis.
Conclusions:
- BRD4 promotes gastric cancer metastasis through a noncanonical posttranscriptional mechanism involving Snail stabilization.
- Targeting BRD4 with existing bromodomain inhibitors may be a viable therapeutic strategy for metastatic gastric cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Eukaryotic Promoter Region
RNA Stability
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

